The DOI matches its Crossref record; 56 of the 59 references it cites were found in a registry or an index.
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Open accessAbstract
Regions of severe oxygen deprivation (hypoxia) arise in tumors due to rapid cell division and aberrant blood vessel formation. The hypoxia-inducible factors (HIFs) mediate transcriptional responses to localized hypoxia in normal tissues and in cancers and can promote tumor progression by altering cellular metabolism and stimulating angiogenesis. Recently, HIFs have been shown to activate specific signaling pathways such as Notch and the expression of transcription factors such as Oct4 that control stem cell self renewal and multipotency. As many cancers are thought to develop from a small number of transformed, self-renewing, and multipotent "cancer stem cells," these results suggest new roles for HIFs in tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The stem cell-like state is mediated by upregulation of OCT4, Notch, c-Myc, and telomerase (Keith & Simon, 2007).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Keith & Simon, 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From a mechanistic standpoint, HIF activation drives tumor progression by coordinating transcriptional programs that promote glycolytic metabolism, angiogenic factor production, cell survival, proliferation, immune evasion, and maintenance of cancer stem like properties [20,250,251].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [251]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Niwa, H., Miyazaki, J., & Smith, A. G. (2000) · Nature Genetics · doi:10.1038/74199 · Cited by 3,904
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Notch signalling: a simple pathway becomes complex
Bray, S. J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2009 · Cited by 2,620
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells
Loh, Y., Wu, Q., Chew, J.-L., Vega, V. B., Zhang, W., Chen, X., Bourque, G., George, J., Leong, B., Liu, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1760 · Cited by 2,438
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,296
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Flagged first, then by citations
3 of the 59 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,000
Jaraba-Álvarez, W. V., Uscanga‐Palomeque, A. C., Sanchez-Giraldo, V., Madrid, C., Ortega-Arellano, H., Halpert-Correa, K., & Quintero-Gil, C. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1609082 · Cited by 19
Bassler, M. C., Rammler, T., Wackenhut, F., Oven‐Krockhaus, S. Z., Secic, I., Ritz, R., Meixner, A. J., & Brecht, M. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04107-2 · Cited by 18
Guo, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.862791 · Cited by 19
Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy
Chen, S., Duan, H., & Sun, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114963 · Cited by 18
Lin, H., Xu, Q., Zhang, F., Wu, H., Hu, B., Chen, G., Ban, X., Duan, X., & Yu, M. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145555 · Cited by 18
Ebrahimie, E., Nik, S. H. M., Newman, M., der Hoek, M. B. V., & Lardelli, M. T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150678 · Cited by 19
Schibler, J., Tomanek‐Chalkley, A., Reedy, J. L., Zhan, F., Spitz, D. R., Schultz, M. K., & Goel, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167323 · Cited by 17
Metabolic Alterations at the Crossroad of Aging and Oncogenesis
Raffaghello, L., & Longo, V. D. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.003 · Cited by 19
Chang, W. H., & Lai, A. G. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.008 · Cited by 17
Lin, C., Li, H., Liu, Y., Kuo, P.-F., Wang, W., Lin, F., Chang, W.-L., Sheu, B., Wang, Y., Hung, W.-C., et al. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919875324 · Cited by 18
Role of Polycomb-group genes in sustaining activities of normal and malignant stem cells
Takihara, Y. (2007) · International Journal of Hematology · doi:10.1007/s12185-007-0006-y · Cited by 18
Pore, N., Jalla, S., Liu, Z., Higgs, B. W., Sorio, C., Scarpa, A., Hollingsworth, R. E., Tice, D. A., & Michelotti, E. F. (2015) · Neoplasia · doi:10.1016/j.neo.2015.05.001 · Cited by 18
Baf155 regulates skeletal muscle metabolism via HIF-1a signaling
Kang, J., Kim, D., Rhee, J., Seo, J., Park, I., Kim, J.-H., Lee, D. S., Lee, W., Kim, Y. L., Yoo, K., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002192 · Cited by 19
Chellini, F., Tani, A., Parigi, M., Palmieri, F., Garella, R., Zecchi‐Orlandini, S., Squecco, R., & Sassoli, C. (2023) · Cells · doi:10.3390/cells12242851 · Cited by 18
Glioblastoma cancer stem cells: Basis for a functional hypothesis
Schiffer, D., Mellai, M., Annovazzi, L., Piazzi, A., Monzeglio, O., & Caldera, V. (2012) · Stem Cell Discovery · doi:10.4236/scd.2012.23017 · Cited by 17
Lu, C.-S., Hsieh, J.-L., Lin, C.-Y., Tsai, H.-W., Su, B.-H., Shieh, G.-S., Su, Y.-C., Lee, C.-H., Chang, M.-Y., Wu, C., et al. (2015) · Gene Therapy · doi:10.1038/gt.2014.122 · Cited by 17
Oral Cancer Stem Cells Microenvironment
Naik, P. P., Panda, P. K., & Bhutia, S. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-69194-7_11 · Cited by 17
Machida, K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7241 · Cited by 18
Han, Z., Zhang, Z., Guan, Y., Chen, B., Yu, M., Zhang, L., Fang, J., Gao, Y., & Guo, Z. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.120 · Cited by 18
Mao, Z., Liu, G., Xiao, G., Zhao, C., & Zou, Y. (2021) · Orthopaedic Surgery · doi:10.1111/os.12883 · Cited by 17
Hypoxia-Mediated Regulation of Stem Cell Fate
Singh, R. P., Franke, K., & Wielockx, B. (2012) · High Altitude Medicine & Biology · doi:10.1089/ham.2012.1043 · Cited by 19
Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma
Gaelzer, M. M., dos Santos, M. S., Coelho, B. P., de Quadros, A. H., Simão, F., Usach, V., Guma, F. T. C. R., Setton-Avruj, C. P., Lenz, G., & Salbego, C. G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0126-6 · Cited by 17
Effect of T wist and B mi1 on intraductal papillary mucinous neoplasm of the pancreas
Ishikawa, D., Shimada, M., Utsunomiya, T., Morine, Y., Imura, S., Ikemoto, T., Arakawa, Y., Kanamoto, M., Iwahashi, S., Saito, Y., et al. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12652 · Cited by 17
Intestinal HIF-2α Regulates GLP-1 Secretion via Lipid Sensing in L-Cells
Mooli, R. G. R., Mukhi, D., Pasupulati, A. K., Evers, S. S., SIPULA, I. J., Jurczak, M. J., Seeley, R. J., Shah, Y. M., & Ramakrishnan, S. K. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.004 · Cited by 16
Hypoxia-Responsive Polymeric Nanoprodrugs for Combo Photodynamic and Chemotherapy
Zhao, D., Zhang, Y., Yan, Z., Ding, Y., & Liang, F. (2023) · ACS Omega · doi:10.1021/acsomega.3c08504 · Cited by 16
Pan, Y., Yu, L., Liu, L., Zhang, J., Liang, S., Parshad, B., Lai, J., Ma, L., Wang, Z., & Rao, L. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.04.008 · Cited by 16
Donovan, L., Potter, N. E., Warr, T. J., & Pilkington, G. J. (2012) · Translational Oncology · doi:10.1593/tlo.11337 · Cited by 16
Normoxic Expression of Hypoxia‐Inducible Factor 1 in Rat Leydig Cells In Vivo and In Vitro
Palladino, M. A., Pirlamarla, P. R., McNamara, J., Sottas, C. M., Korah, N., Hardy, M. P., Hales, D. B., & Hermo, L. (2011) · Journal of Andrology · doi:10.2164/jandrol.110.011494 · Cited by 16
VHL Deletion Impairs Mammary Alveologenesis but Is Not Sufficient for Mammary Tumorigenesis
Seagroves, T. N., Peacock, D. L., Liao, D., Schwab, L. P., Krueger, R. L., Handorf, C. R., Haase, V. H., & Johnson, R. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090310 · Cited by 15
Multimodality Approaches to Treat Hypoxic Non-Small Cell Lung Cancer (NSCLC) Microenvironment
Liang, S., Galluzzo, P., Sobol, A., Skucha, S., Rambo, B., & Bocchetta, M. (2012) · Genes & Cancer · doi:10.1177/1947601912457025 · Cited by 16
Khoei, S., Shoja, M., Mostaar, A., & Faeghi, F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370215622583 · Cited by 16
Musashi mediates translational repression of theDrosophilahypoxia inducible factor
Bertolin, A. P., Katz, M. J., Yano, M., Pozzi, B., Acevedo, J. M., Blanco-Obregon, D., Gándara, L., Sorianello, E. M., Kanda, H., Okano, H., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw372 · Cited by 16
Daly, C. S., Flemban, A. F., Shafei, M. A., Conway, M. E., Qualtrough, D., & Dean, S. (2017) · Oncology Reports · doi:10.3892/or.2017.6125 · Cited by 17
Menon, A., Creo, P., Piccoli, M., Bergante, S., Conforti, E., Banfi, G., Randelli, P. S., & Anastasia, L. (2018) · Stem Cells International · doi:10.1155/2018/9468085 · Cited by 15
OCT4B mediates hypoxia-induced cancer dissemination
Lin, S.-C., Chung, C.-H., Chung, C.-H., Kuo, M.-H., Hsieh, C.-H., Chiu, Y.-F., Shieh, Y., Chou, Y., & Wu, C.-W. (2018) · Oncogene · doi:10.1038/s41388-018-0487-6 · Cited by 15
Coelho, D. R., Palma, F. R., Paviani, V., He, C., Danes, J. M., Huang, Y., Calado, J. C. P., Hart, P. C., Furdui, C. M., Poole, L. B., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110348119 · Cited by 17
D’Andrea, F. P. (2012) · PubMed · Cited by 16
Ambrosini, S., Sarchielli, E., Comeglio, P., Porfirio, B., Gallina, P., Morelli, A., & Vannelli, G. B. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.073 · Cited by 16
Sun, C., Song, H., Zhang, H., Hou, C., Zhai, T., Huang, L., & Zhang, L. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1237-8 · Cited by 16
Liprin-α4 is a new hypoxia-inducible target gene required for maintenance of cell–cell contacts
Mattauch, S., Sachs, M., & Behrens, J. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.06.022 · Cited by 17
Frazier, T. P., McLachlan, J. B., Gimble, J. M., Tucker, H. A., & Rowan, B. G. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0152 · Cited by 16
Yeung, T. M., & Mortensen, N. J. M. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181a8738c · Cited by 16
The expanding universe of hypoxia
Zhang, H., & Semenza, G. L. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0364-9 · Cited by 17
Cancer Stem Cells - Therapeutic Boon!
Shrihari, T. G. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000088 · Cited by 16
Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma
Kambayashi, S., Igase, M., Kobayashi, K., KIMURA, A., MIYAMA, T. S., Baba, K., Noguchi, S., Mizuno, T., & Okuda, M. (2015) · Journal of Veterinary Medical Science · doi:10.1292/jvms.15-0258 · Cited by 15
Liu, X., Cui, Y., Gong, J., Yu, X., Cui, Y., & Xuan, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03426-9 · Cited by 15
Prostate cancer stem cell dynamics in the evolution of drug resistance
Zhang, X., Zhang, X., Deng, X., Cao, J., Bao, Q., Wang, H., Chen, D., & Tang, H. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002611 · Cited by 15
Probiotics in Counteracting the Role of Neutrophils in Cancer Metastasis
Mangrolia, U., & Osborne, J. W. (2021) · Vaccines · doi:10.3390/vaccines9111306 · Cited by 15
Zhang, T., Zheng, B., Xia, C., Wu, P., Zheng, B., Jiang, L., Li, J., Lv, G., Zhou, H., Huang, W., et al. (2024) · Advanced Science · doi:10.1002/advs.202405421 · Cited by 15
Isolation and Applications of Prostate Side Population Cells Based on Dye Cycle Violet Efflux
Gangavarapu, K. J., & Huss, W. J. (2011) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2202s47 · Cited by 15
Gao, X. C., Guo, X., Xue, H., Qiu, W., Guo, X., Zhang, J., Qian, M., Li, T., Liu, Q., Shen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17340-y · Cited by 15
Faria, M., Karami, S., Granados-Principal, S. M., Dey, P., Verma, A., Choi, D. S., Elemento, O., Bawa‐Khalfe, T., Chang, J. C., Ström, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24134 · Cited by 15
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?
Boldrini, L., Bartoletti, R., Giordano, M., Manassero, F., Selli, C., Panichi, M., Galli, L., Farci, F., & Faviana, P. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0479-4 · Cited by 15
PFT1-controlled ROS balance is critical for multiple stages of root hair development in Arabidopsis
Kalaipandian, S., Chandrika, N. N. P., Tsai, Y.-H., & Schmidt, W. (2013) · Plant Signaling & Behavior · doi:10.4161/psb.24066 · Cited by 15
Implications of Oxygen Homeostasis for Tumor Biology and Treatment
Garvalov, B. K., & Acker, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_12 · Cited by 17
Sridharan, P., Vinothkumar, G., Pratheesh, P., & Babu, K. S. (2020) · Journal of Materials Science · doi:10.1007/s10853-020-04872-4 · Cited by 15
Tye, S. L., Gilg, A. G., Tolliver, L. B., Wheeler, W. G., Toole, B. P., & Maria, B. L. (2008) · Journal of Child Neurology · doi:10.1177/0883073808321066 · Cited by 15
NSD1 promotes esophageal cancer tumorigenesis via HIF1α signaling
He, F., Xiao, H., Cai, Y., & Zhang, N. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09786-2 · Cited by 14
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Lamichhane, A., & Tavana, H. (2024) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-024-00798-y · Cited by 16
Baumann, G. K., Travieso, L. G., Liebl, D. J., & Theus, M. H. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213494558 · Cited by 14
Okamoto, M., Takahashi, Y., Komichi, S., Ali, M., Watanabe, M., & Hayashi, M. (2019) · International Endodontic Journal · doi:10.1111/iej.13099 · Cited by 13
Chiu, H. ‐., Lee, H., Lee, K. ‐., Zhao, Y. D., Hsu, C. Y., & Shyu, W. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12585 · Cited by 14
Nagata, A., Itoh, F., Sasho, A., Sugita, K., Suzuki, R., Hinata, H., Shimoda, Y., Suzuki, E., Maemoto, Y., Inagawa, T., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011222 · Cited by 14
Jang, G., Oh, J., Jun, E., Lee, J. L., Kwon, J. Y., Kim, J., Lee, S., Kim, S. C., Cho, S., & Lee, C. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00333-w · Cited by 14
Morrison, J. K., Friday, A. J., Henderson, M. A., Hao, E., & Keiper, B. D. (2014) · Translation · doi:10.4161/trla.28935 · Cited by 13
A Unique 3D In Vitro Cellular Invasion Assay
Quail, D. F., Maciel, T. J., Rogers, K. A., & Postovit, L.-M. M. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112449863 · Cited by 14
Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L
Song, C., Xu, Q., Jiang, K., Zhou, G., Yu, X., Wang, L., Zhu, Y., Fang, L., Yu, Z. S., Lee, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5337 · Cited by 14
SINHCAF/FAM60A and SIN3A specifically repress HIF-2α expression
Biddlestone, J., Batie, M., Shmakova, A., Bandarra, D., Knatko, E. V., Dinkova‐Kostova, A. T., Munoz, I. M., Sundaramoorthy, R., Owen-Hughes, T., & Rocha, S. (2018) · Biochemical Journal · doi:10.1042/bcj20170945 · Cited by 17
CD 133: holy of grail of neuro‐oncology or promiscuous red‐herring?
Donovan, L., & Pilkington, G. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00842.x · Cited by 13
Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins
Rashed, F. B., Stoica, C., Macdonald, D., Elsaidi, H. R. H., Ricardo, C., Bhatt, B., Moore, J., Diaz‐Dussan, D., Ramamonjisoa, N., Mowery, Y. M., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101905 · Cited by 14
Fracture repair by IOX2: Regulation of the hypoxia inducible factor-1α signaling pathway and BMSCs
Chen, C., Yan, S., Geng, Z., & Wang, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174864 · Cited by 13
A Role of Non-FDG Tracers in Lung Cancer?
Novruzov, E., Mori, Y., Antke, C., Dabir, M., Schmitt, D. R., Kratochwil, C., Koerber, S. A., Haberkorn, U., & Giesel, F. L. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.05.004 · Cited by 13
Murnan, K., Horbinski, C., & Stegh, A. H. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0262 · Cited by 15
Redox System and Oxidative Stress-Targeted Therapeutic Approaches in Bladder Cancer
Dugbartey, G. J., Relouw, S., McFarlane, L., & Şener, A. (2024) · Antioxidants · doi:10.3390/antiox13030287 · Cited by 13
Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Leirós, G. J., & Balañá, M. E. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798377094 · Cited by 13
Yang, Y., Jiang, Z., Bolnick, A. D., Dai, J., Puscheck, E. E., & Rappolee, D. A. (2016) · Journal of Reproduction and Development · doi:10.1262/jrd.2016-110 · Cited by 13
Ma, C.-N., Wo, L., Wang, D.-F., Zhou, C.-X., Li, J.-C., Zhang, X., Gong, X.-F., Wang, C.-L., He, M., & Zhao, Q. (2021) · RNA Biology · doi:10.1080/15476286.2020.1871215 · Cited by 13
Cao, X., Wu, W., Wang, D. W., Sun, W., & Lai, S. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00825-3 · Cited by 13
Road testing new CAR design strategies in multiple myeloma
Rana, P. S., Murphy, E. V., Kort, J., & Driscoll, J. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957157 · Cited by 14
Qin, M., Liu, Q., Yang, W., Wang, Q., & Xiang, Z. (2022) · Cancer Medicine · doi:10.1002/cam4.5562 · Cited by 13
Cell type-specific reciprocal regulation of HIF1A gene expression is dependent on 5′- and 3′-UTRs
Yasuda, M., Hatanaka, T., Shirato, H., & Nishioka, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.058 · Cited by 14
Interactions between oxygen homeostasis, food availability, and hydrogen sulfide signaling
Iranon, N. N., & Miller, D. L. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00257 · Cited by 14
Gallagher, M. F., Heffron, C. C. B. B., Laios, A., O’Toole, S. A., Ffrench, B., Smyth, P. C., Flavin, R., Elbaruni, S. A., Spillane, C. D., Martin, C. M., et al. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-2 · Cited by 13
Osteonecrosis of the femoral head: treatment with ancillary growth factors
Houdek, M. T., Wyles, C. C., & Sierra, R. J. (2015) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-015-9281-z · Cited by 13
Yu, Y., Wang, Y., Wang, Y., Wang, X., Liu, Y., Wang, J., Du, C., Wang, L., Li, M., Luo, F., et al. (2016) · Scientific Reports · doi:10.1038/srep34239 · Cited by 13
Maralani, P. J., Das, S., Mainprize, T. G., Phan, N., Bharatha, A., Keith, J. L., Muñoz, D. G., Sahgal, A., Symons, S. P., Ironside, S., et al. (2018) · Radiology · doi:10.1148/radiol.2018172601 · Cited by 13
Wang, Z., Khor, S., & Cai, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005429 · Cited by 13
Biomaterial Platform To Establish a Hypoxic Metastatic Niche in Vivo
Lee, H. R., Pelaez, F., Silbaugh, A. M., Leslie, F., Racila, E. V., & Azarin, S. M. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00837 · Cited by 14
New Treatment Strategies to Eradicate Cancer Stem Cells and Niches in Glioblastoma
Hide, T., Makino, K., Nakamura, H., Yano, S., Anai, S., Takezaki, T., Kuroda, J.-I., Shinojima, N., Yutaka, U. E. D. A., & Kuratsu, J. (2013) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra2013-0207 · Cited by 13
Tumor exosomes impact functional hallmarks of cancer
Laein, M. H., Thinakaran, Y., Katoueezadeh, M., Iyappan, R., Baker, J., Kalailingam, P., Ngan, S. C., McCarthy, N. E., Klentrou, P., Tsiani, E., et al. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10333-2 · Cited by 13
Strohmayer, C., Klang, A., Kummer, S., Walter, I., Jindra, C., Weissenbacher‐Lang, C., Redmer, T., Kneissl, S. M., & Brandt, S. (2022) · Pathogens · doi:10.3390/pathogens11020266 · Cited by 13
Kocemba-Pilarczyk, K. A., Ostrowska, B., Trojan, S., Aslan, E., Kusior, D., Lasota, M., Lenouvel, C., & Dulińska-Litewka, J. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2018_1630 · Cited by 12
Wang, H., Li, Z., Tao, Y., Ou, S., Ye, J., Ran, S., Luo, K., Guan, Z., Xiang, J. Y., Yan, G., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04547-z · Cited by 12
Beckers, C., Vasilikos, L., Sánchez‐Fernández, A., Moor, L., & Pruschy, M. N. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.110039 · Cited by 12
Exploring human pancreatic organoid modelling through single-cell RNA sequencing analysis
Cherubini, A., Rusconi, F., Piras, R., Wächtershäuser, K. N., Dossena, M., Barilani, M., Mei, C., Hof, L., Sordi, V., Pampaloni, F., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07193-3 · Cited by 13
Improving cellular fitness of human stem cell-derived islets under hypoxia
Wang, X., Brielle, S., Kenty, J. H.-R., Korover, N., Bavli, D., Pop, R., & Melton, D. A. (2025) · Nature Communications · doi:10.1038/s41467-025-59924-7 · Cited by 14
Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach
Peppicelli, S., Bianchini, F., & Calorini, L. (2015) · Oncoscience · doi:10.18632/oncoscience.123 · Cited by 12
Khalesi, E., Nakamura, H., Lee, K. L., Putra, A. C., Fukazawa, T., Kawahara, Y., Makino, Y., Poellinger, L., Yuge, L., & Tanimoto, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.083 · Cited by 12
Tumor‐initiating cells and tumor vascularization
Zhang, L., Zhang, C., Yan, Z., Yang, Q., Jiang, Y. X., & Zeng, B. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22886 · Cited by 12
Modeling head and neck cancer stem cell-mediated tumorigenesis
Pearson, A. T., Jackson, T. L., & Nor, J. E. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2226-x · Cited by 13
Metadata
- Authors
- Keith, B., & Simon, M. C.
- Affiliations
- University of Pennsylvania (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Keith, Brian
- Simon, M. Celeste
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 129
- Issue
- 3
- Pages
- 465-472
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3150586
- OpenAlex
- W1973541913
- Cited by
- 1,179
- References
- 59
- Citations by year
- 2026: 32 · 2025: 49 · 2024: 54 · 2023: 49 · 2022: 68 · 2021: 62 · 2020: 62 · 2019: 58 · 2018: 62 · 2017: 74 · 2016: 63 · 2015: 81 · 2014: 84 · 2013: 80 · 2012: 72
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2269 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL66130, R01HL066130)
- Core Research for Evolutional Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- hypoxia-inducible factor, tumor hypoxia, cancer stem cells, stem cell self-renewal, tumor angiogenesis, Notch signaling, Oct4, tumor progression, cellular metabolism, transcriptional regulation
- MeSH terms
- Animals, Hypoxia, Humans, Neoplasms, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Cell Hypoxia, Disease Progression, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review